UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 15, 2017

 

MEDICAL TRANSCRIPTION BILLING, CORP.
(Exact name of registrant as specified in its charter)

 

Delaware   333-192989   22-3832302
(State or other jurisdiction
of incorporation)		   (Commission
File Number)		   (IRS Employer
Identification No.)

 

7 Clyde Road, Somerset, New Jersey, 08873
(Address of principal executive offices, zip code)

 

(732) 873-5133

(Registrant's telephone number, including area code)

 

Not Applicable
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 
  

 

Item 5.07 Submission of Matters to a Vote of Security Holders:

 

The Company held its Annual Meeting on June 15, 2017 in Somerset, New Jersey. As of April 17, 2017, the record date, there were 10,487,677 shares of Common Stock outstanding. The proposal considered at the Annual Meeting is described in detail in the Proxy Statement as filed on April 14, 2017 with the Securities and Exchange Commission. The proposal described below was voted upon at the Annual Meeting and the number of votes cast with respect to such proposal was as follows:

 

1.Election of Directors:

 

Name   For   Against   Abstain   % of Shares Voted   Total Shares Voted
Mahmud Haq   6,552,491   0   1,000   62.49%   6,553,491
Cameron Munter   6,553,491   0   0   62.49%   6,553,491

 

2
  

 

SIGNATURE(S)

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

 

Medical Transcription Billing, Corp.

 

Date: June 20, 2017

By:

 /s/ Mahmud Haq
   

Mahmud Haq

Chairman of the Board and Chief Executive Officer

 

3